| Financial Year |
March 31 2023 |
| Monetary Funds |
1,773,872,739.69 |
| Held-for-trading Financial Assets |
29,426,808.70 |
| Notes Receivable |
-- |
| Accounts Receivable |
986,266,040.28 |
| Advances to Suppliers |
61,945,828.16 |
| Other Receivables |
173,124,043.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
349,454,364.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,611,535.84 |
| Total Current Assets |
3,538,631,959.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
683,891,857.47 |
| Investment Properties |
159,486,798.77 |
| Fixed Assetes |
21,519,293,591.69 |
| Under-construction Projects |
761,628,382.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,748,419,330.50 |
| R&D expenses |
-- |
| Goodwill |
3,268,200.00 |
| Long-Term Deferred and Prepaid Expenses |
3,641,240,364.98 |
| Deferred Income Tax Assets |
193,193,870.08 |
| Other Non-Current Assets |
1,662,367,084.82 |
| Sub-Total of Non-Current Assets |
30,484,789,042.59 |
| Total Assets |
34,023,421,002.23 |
| Short-Term Loans |
1,330,576,619.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
169,210,000.00 |
| Accounts Payable |
1,922,476,842.04 |
| Accounts Received In Advance |
341,116.99 |
| Employee Compensation Payable |
1,079,688,036.61 |
| Taxes Payable |
729,862,820.72 |
| Interest Payable |
-- |
| Dividend Payable |
49,808,553.04 |
| Other payables |
765,276,539.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,959,528,173.45 |
| Other Current Liabilities |
30,798,492.30 |
| Sub-Total of Current Liabilities |
9,238,341,759.20 |
| Long-term Loans |
9,039,202,225.65 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
748,271,111.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,633,184,116.72 |
| Deferred Income Tax Liabilities |
24,544,201.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,637,355,944.69 |
| Total Liabilities |
20,875,697,703.89 |
| Paid-In Capital(Or Share Stock) |
2,590,541,800.00 |
| Capital Surplus |
2,154,689,316.23 |
| Surplus Reserve |
1,236,010,614.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,323,436,074.76 |
| Minority Stockholder's Interest |
976,801,091.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,170,922,207.09 |
| Owner's Equity（Stockholder's Equity） |
13,147,723,298.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
34,023,421,002.23 |
